Could treating the whole family stop malaria in pregnancy?
NCT ID NCT07021430
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times
Summary
This pilot study tests whether giving a malaria drug (dihydroartemisinin piperaquine) to household members of pregnant women can help prevent malaria in the mothers. About 300 participants in Uganda will receive either a single dose or monthly doses. The goal is to see if this approach is feasible, acceptable, and shows early signs of working.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dihydroartemisinin Piperaquine (a malaria drug)
- What this could lead to
- If it works, this could point toward a new way to protect pregnant women from malaria by treating their family members.
- What could go wrong
- This is a very early pilot study with only 300 people, so it may not show clear benefits or be too small to prove effectiveness. The approach may also be hard to scale or accept in communities.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA PREVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bugoye Level III Health Center
Kasese, Uganda, Uganda
More trials for these conditions
Other studies related to the condition(s) this trial covers.